SavedAdd your journal

Journals / İstanbul Kuzey Klinikleri / 2020 / Cilt: 7 - Sayı: 1

A case of Kawasaki disease presenting with atypical cutaneous involvement and mimicking Stevens-Johnson syndrome

Ferhat DEMİR
Embiya DİLBER
Fazıl ORHAN
Mukaddes KALYONCU
Mehtap HAKTANIR ABUL
Pages
67–70
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, it may lead to confusion in diagnosis with Stevens-Johnson syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kawasaki disease is the second most common cause of childhood vasculitis.
📊
Key Findings & Data:A 14-month-old girltreated with intravenous immunoglobulin after diagnosed with KD.
💡
Conclusion & Impact:Thus, it may lead to confusion in diagnosis with Stevens-Johnson syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Kawasaki disease is the second most common cause of childhood vasculitis. Cutaneous manifestation, which is the diagnosticcriteria of Kawasaki disease, may show atypical course and causes conflict in diagnosis for physicians. A 14-month-old girltreated with intravenous immunoglobulin after diagnosed with KD. Target lesions and a vesicular rash developed on the wholebody during the course of the disease. Methylprednisolone was added to the treatment. All atypical skin lesions and diseasefindings were improved using IVIG and subsequent methylprednisolone therapy. Cutaneous signs of KD may show atypicalcourse. Thus, it may lead to confusion in diagnosis with Stevens-Johnson syndrome.

🔖

Cite This Article

DEMİR, F., DİLBER, E., ORHAN, F., KALYONCU, M., ABUL, M. H. (2022). A case of Kawasaki disease presenting with atypical cutaneous involvement and mimicking Stevens-Johnson syndrome. İstanbul Kuzey Klinikleri, Cilt: 7 - Sayı: 1, 67–70. https://ajindex.com/articles/551382

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Burns JC, Glodé MP. Kawasaki syndrome. Lancet 2004;364:533–44. 2. Stadelman PM, Jaouen RM, Wang SF. Mucocutaneous lymph node syndrome with vesicles. J Med Soc N J 1978;75:56–8. 3. Kwan YW, Leung CW. Pustulo-vesicular skin eruption in a child with probable Kawasaki disease. Eur J Pediatr 2005;164:770–1. 4. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747–71. 5. Kimura T, Miyazawa H, Watanabe K, Moriya T. Small pustules in Kawasaki disease. A clinicopathological study of four patients. Am J Dermatopathol 1988;10:218–23. 6. Eberhard BA, Sundel RP, Newburger JW, Baker A, Fuhlbrigge RC, Burns JC, et al. Psoriatic eruption in Kawasaki disease. J Pediatr 2000;137:578–80. 7. Ming A, Wargon O. Annular lesions in Kawasaki disease: a cause of confusion. Australas J Dermatol 2008;49:207–12. 8. Eun LY, Go JW, Kang WH, Kim SH, Cho HK. Erythema multiforme associated with Kawasaki Disease in a Korean child. Eur J Dermatol 2010;20:524–5. 9. Vierucci F, Tuoni C, Moscuzza F, Saggese G, Consolini R. Erythema multiforme as first sign of incomplete Kawasaki disease. Ital J Pediatr 2013;39:11. 10. French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our currentunderstanding. Allergol Int 2006;55:9–16. 11. Hurelbrink CB, Spies JM, Yiannikas C. Significant dermatological side effects of intravenous immunoglobulin. J Clin Neurosci 2013;20:1114– 6. 12. Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol 2005;29:173–84. 13. Lin WL, Lin WC, Chang YC, Yang LC, Hung SI, Hong HS, et al. Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome. Am J Clin Dermatol 2009;10:339–42.